Global Sustained release Medicine Industry

2023-2029 Global Sustained-release Medicine Industry Research & Trends Analysis Report

Global Sustained release Medicine Industry

2023-2029 Global Sustained-release Medicine Industry Research & Trends Analysis Report


Insights into the Sustained-release Medicine Market include supply chain optimization, Sustained-release Medicine challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to the research report published by Market IntelliX, the global market for Sustained-release Medicine should grow from US$ 34850 million in 2022 to US$ 55040 million by 2029, with a CAGR of 6.9% for the period of 2023-2029.

The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.

Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D

This report aims to provide a comprehensive study of the global market for Sustained-release Medicine. Report Highlights:

(1) Global Sustained-release Medicine market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Sustained-release Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Sustained-release Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Sustained-release Medicine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Sustained-release Medicine segment by type and by application and regional segment by type and by application.

(6) Sustained-release Medicine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Original Ground Medicine

Generic Medicine

Market segment by distribution channel, can be divided into

Hospital

Drugstore

Other

Market segment by players, this report covers

Sanofi

Novartis

Bayer

Johnson & Johnson

Takeda

AstraZeneca

AbbVie

Pfizer

Collegium Pharmaceutical, Inc

Endo Pharmaceuticals

Shanghai Shyndec Pharmaceutical

Zhuhai Rundu Pharmaceutical

China Res Double-Crane

1 Market Overview

1.1 Product Overview and Scope of Sustained-release Medicine

1.2 Global Sustained-release Medicine Market Size and Forecast

1.3 China Sustained-release Medicine Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Sustained-release Medicine Share in Global Market, 2018-2029

1.4.2 Sustained-release Medicine Market Size: China VS Global, 2018-2029

1.5 Sustained-release Medicine Market Dynamics

1.5.1 Sustained-release Medicine Market Drivers

1.5.2 Sustained-release Medicine Market Restraints

1.5.3 Sustained-release Medicine Industry Trends

1.5.4 Sustained-release Medicine Industry Policy

2 Global Competitive Situation by Company

2.1 Global Sustained-release Medicine Revenue by Company (2018-2023)

2.2 Global Sustained-release Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Sustained-release Medicine Concentration Ratio

2.4 Global Sustained-release Medicine Mergers & Acquisitions, Expansion Plans

2.5 Global Sustained-release Medicine Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Sustained-release Medicine Revenue by Company (2018-2023)

3.2 China Sustained-release Medicine Sustained-release Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Sustained-release Medicine, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Sustained-release Medicine Industry Chain

4.2 Sustained-release Medicine Upstream Analysis

4.3 Sustained-release Medicine Midstream Analysis

4.4 Sustained-release Medicine Downstream Analysis

5 Sights by Type

5.1 Sustained-release Medicine Classification

5.1.1 Original Ground Medicine

5.1.2 Generic Medicine

5.2 By Type, Global Sustained-release Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Sustained-release Medicine Revenue, 2018-2029

6 Sights by Distribution Channel

6.1 Sustained-release Medicine Segment by Distribution Channel

6.1.1 Hospital

6.1.2 Drugstore

6.1.3 Other

6.2 By Application, Global Sustained-release Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Sustained-release Medicine Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Sustained-release Medicine Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Sustained-release Medicine Market Size, 2018-2029

7.3 North America

7.3.1 North America Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Sustained-release Medicine Market Size Market Share

7.4 Europe

7.4.1 Europe Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Sustained-release Medicine Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Sustained-release Medicine Market Size Market Share

7.6 South America

7.6.1 South America Sustained-release Medicine Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Sustained-release Medicine Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Sustained-release Medicine Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Sustained-release Medicine Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Sustained-release Medicine Market Size, 2018-2029

8.3.2 By Company, U.S. Sustained-release Medicine Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.3.4 By Distribution Channel, U.S. Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Sustained-release Medicine Market Size, 2018-2029

8.4.2 By Company, Europe Sustained-release Medicine Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.4.4 By Distribution Channel, Europe Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Sustained-release Medicine Market Size, 2018-2029

8.5.2 By Company, China Sustained-release Medicine Revenue Market Share, 2018-2023

8.5.3 By Type, China Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.5.4 By Distribution Channel, China Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Sustained-release Medicine Market Size, 2018-2029

8.6.2 By Company, Japan Sustained-release Medicine Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.6.4 By Distribution Channel, Japan Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Sustained-release Medicine Market Size, 2018-2029

8.7.2 By Company, South Korea Sustained-release Medicine Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.7.4 By Distribution Channel, South Korea Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Sustained-release Medicine Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Sustained-release Medicine Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.8.4 By Distribution Channel, Southeast Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Sustained-release Medicine Market Size, 2018-2029

8.9.2 By Company, India Sustained-release Medicine Revenue Market Share, 2018-2023

8.9.3 By Type, India Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.9.4 By Distribution Channel, India Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Sustained-release Medicine Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

8.10.4 By Distribution Channel, Middle East & Asia Sustained-release Medicine Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Sanofi

9.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.1.2 Sanofi Company Profile and Main Business

9.1.3 Sanofi Sustained-release Medicine Models, Specifications and Application

9.1.4 Sanofi Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.1.5 Sanofi Recent Developments

9.2 Novartis

9.2.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.2.2 Novartis Company Profile and Main Business

9.2.3 Novartis Sustained-release Medicine Models, Specifications and Application

9.2.4 Novartis Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.2.5 Novartis Recent Developments

9.3 Bayer

9.3.1 Bayer Company Information, Head Office, Market Area and Industry Position

9.3.2 Bayer Company Profile and Main Business

9.3.3 Bayer Sustained-release Medicine Models, Specifications and Application

9.3.4 Bayer Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.3.5 Bayer Recent Developments

9.4 Johnson & Johnson

9.4.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.4.2 Johnson & Johnson Company Profile and Main Business

9.4.3 Johnson & Johnson Sustained-release Medicine Models, Specifications and Application

9.4.4 Johnson & Johnson Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.4.5 Johnson & Johnson Recent Developments

9.5 Takeda

9.5.1 Takeda Company Information, Head Office, Market Area and Industry Position

9.5.2 Takeda Company Profile and Main Business

9.5.3 Takeda Sustained-release Medicine Models, Specifications and Application

9.5.4 Takeda Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.5.5 Takeda Recent Developments

9.6 AstraZeneca

9.6.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

9.6.2 AstraZeneca Company Profile and Main Business

9.6.3 AstraZeneca Sustained-release Medicine Models, Specifications and Application

9.6.4 AstraZeneca Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.6.5 AstraZeneca Recent Developments

9.7 AbbVie

9.7.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.7.2 AbbVie Company Profile and Main Business

9.7.3 AbbVie Sustained-release Medicine Models, Specifications and Application

9.7.4 AbbVie Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.7.5 AbbVie Recent Developments

9.8 Pfizer

9.8.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.8.2 Pfizer Company Profile and Main Business

9.8.3 Pfizer Sustained-release Medicine Models, Specifications and Application

9.8.4 Pfizer Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.8.5 Pfizer Recent Developments

9.9 Collegium Pharmaceutical, Inc

9.9.1 Collegium Pharmaceutical, Inc Company Information, Head Office, Market Area and Industry Position

9.9.2 Collegium Pharmaceutical, Inc Company Profile and Main Business

9.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Models, Specifications and Application

9.9.4 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.9.5 Collegium Pharmaceutical, Inc Recent Developments

9.10 Endo Pharmaceuticals

9.10.1 Endo Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

9.10.2 Endo Pharmaceuticals Company Profile and Main Business

9.10.3 Endo Pharmaceuticals Sustained-release Medicine Models, Specifications and Application

9.10.4 Endo Pharmaceuticals Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.10.5 Endo Pharmaceuticals Recent Developments

9.11 Shanghai Shyndec Pharmaceutical

9.11.1 Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.11.2 Shanghai Shyndec Pharmaceutical Company Profile and Main Business

9.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Models, Specifications and Application

9.11.4 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.11.5 Shanghai Shyndec Pharmaceutical Recent Developments

9.12 Zhuhai Rundu Pharmaceutical

9.12.1 Zhuhai Rundu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

9.12.2 Zhuhai Rundu Pharmaceutical Company Profile and Main Business

9.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Models, Specifications and Application

9.12.4 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.12.5 Zhuhai Rundu Pharmaceutical Recent Developments

9.13 China Res Double-Crane

9.13.1 China Res Double-Crane Company Information, Head Office, Market Area and Industry Position

9.13.2 China Res Double-Crane Company Profile and Main Business

9.13.3 China Res Double-Crane Sustained-release Medicine Models, Specifications and Application

9.13.4 China Res Double-Crane Sustained-release Medicine Revenue and Gross Margin, 2018-2023

9.13.5 China Res Double-Crane Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Sustained-release Medicine Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Is the Sustained-release Medicine Market shifting its focus from growth to value?
Recognize the areas along the Sustained-release Medicine Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
What is the expected rate of growth in the Sustained-release Medicine Market?
From 2025 to 2030, the Sustained-release Medicine Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What does the future hold for the Sustained-release Medicine Market?
As the shift to value addition continues, companies in the Sustained-release Medicine Market face the dual challenge of improving interoperability to optimize performance and experience.
What are the top priorities for the growth of the Sustained-release Medicine Market?
In this highly competitive and rapidly evolving Sustained-release Medicine Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.